The IAM Daily is out! https://t.co/hA5p199MGc
Ford has been at forefront of patent strategy in the auto sector for a while now. Kudos to Bill Coughlin & team. https://t.co/uk9R8PzRTT
Uncertainty in US market and globalisation have driven more patents owners to look closely at China and Europe. https://t.co/n0BEYUstfZ
It's a multi-polar IP market out there these days, with Europe and China starting to give the US a game
It was hard not to be struck by the optimism in the air at IPBC Asia 2016, which took place in Shanghai earlier this week. With well over 400 delegates from major IP owners across the region and beyond in attendance, as well as advisers and intermediaries, the panel sessions and networking breaks gave as good an indication as you could find of the state of IP value creation in some...
CSIRO sees “virtuous cycle” in reinvesting patent monetisation cash directly into commercialisation push
The Commonwealth Scientific and Industrial Research Organisation (CSIRO) – Australia’s national R&D agency – announced this week the creation of a new technology commercialisation fund that will be capitalised using patent assertion and licensing revenues. According to a press release, the CSIRO Innovation Fund will “support co-investment in new spin-out and...
Supreme Court rules in favour of Samsung in Apple patent case but again leaves key questions unanswered
The Supreme Court sided with Samsung on Tuesday when it decided that the Korean tech giant was not on the hook for $399 million in damages for infringing three design patents owned by Apple. In a relatively brief and narrowly constructed nine-page opinion, a unanimous court ruled that in a device as multi-faceted as a smartphone, the article of manufacture need not be considered to be the...
Under threat from investors and generic rivals, pharma and biotech have become staunch opponents of the inter partes review regime. However, as they push for reform, they face a stiff challenge from the US Patent and Trademark Office and Congress
IAM Patent 1000
The definitive guide to leading patent lawyers, attorneys and firms in over 40 jurisdictions, with a special section on expert witnesses in the United States.Visit site